- Home
- ZUMZ vs FATE Comparison
ZUMZ vs FATE Comparison
Compare ZUMZ & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZUMZ | FATE |
|---|---|---|
| Founded | 1978 | 2007 |
| Country | United States | United States |
| Employees | 9000 | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 214.6M | 260.0M |
| IPO Year | 2005 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ZUMZ | FATE |
|---|---|---|
| Price | $13.99 | $1.29 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $5.72 |
| AVG Volume (30 Days) | 226.0K | ★ 1.5M |
| Earning Date | 12-03-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 966.67 | 29.88 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $929,057,000.00 | $6,646,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.92 | $18.72 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 4.48 | N/A |
| 52 Week Low | $13.07 | $0.95 |
| 52 Week High | $31.70 | $3.23 |
Technical Indicators
Market Signals| Indicator | ZUMZ | FATE |
|---|---|---|
| Relative Strength Index (RSI) | 45.30 | 23.18 |
| Support Level | $13.21 | $1.07 |
| Resistance Level | $14.86 | $1.38 |
| Average True Range (ATR) | 0.66 | 0.16 |
| MACD | -0.04 | -0.07 |
| Stochastic Oscillator | 15.47 | 7.35 |
Price Performance
Historical ComparisonAbout ZUMZ Zumiez Inc.
Zumiez Inc is a United States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art, action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.